 SOUTH SAN FRANCISCO, Calif., Nov. 18, 2021 GLOBE NEWSWIRE -- Pliant Therapeutics, Inc. Nasdaq: PLRX, a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., Pliants President and Chief Executive Officer, along with members of Pliants senior management team, will participate in virtual fireside chats at the following investor conferences: 